Steven Cohen's RXRX Position Overview
Steven Cohen (via Point72 Asset Management, L.P.) currently holds 654,211 shares of Recursion Pharmaceuticals, Inc. (RXRX) worth $2.68 M, representing 0.00% of the portfolio. First purchased in 2023-Q3, this short-term holding has been held for 5 quarters.
Based on 13F filings, Steven Cohen has maintained this position in RXRX for several quarters, showing initial confidence in the investment. Largest addition occurred in Q4 2023, adding 1.33 M shares. Largest reduction occurred in Q1 2024, reducing 1.07 M shares.
Analysis based on 13F filings available since 2013 Q2
Steven Cohen's Recursion Pharmaceuticals (RXRX) Holding Value Over Time
Track share changes against reported price movement
Quarterly Recursion Pharmaceuticals (RXRX) Trades by Steven Cohen
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | +654,211 | New Buy | 654,211 | $4.09 |
| Q2 2024 | -400,700 | Sold Out | 0 | $0.00 |
| Q1 2024 | -1.07 M | Reduce 72.75% | 400,700 | $9.97 |
| Q4 2023 | +1.33 M | Add 969.24% | 1.47 M | $9.86 |
| Q3 2023 | +137,500 | New Buy | 137,500 | $7.65 |
Steven Cohen's Recursion Pharmaceuticals Investment FAQs
Steven Cohen first purchased Recursion Pharmaceuticals, Inc. (RXRX) in Q3 2023, acquiring 137,500 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Steven Cohen has held Recursion Pharmaceuticals, Inc. (RXRX) for 5 quarters since Q3 2023.
Steven Cohen's largest addition to Recursion Pharmaceuticals, Inc. (RXRX) was in Q4 2023, adding 1,470,200 shares worth $14.5 M.
According to the latest 13F filing for Q4 2025, Steven Cohen's firm, Point72 Asset Management, L.P., owns 654,211 shares of Recursion Pharmaceuticals, Inc. (RXRX), valued at approximately $2.68 M.
As of the Q4 2025 filing, Recursion Pharmaceuticals, Inc. (RXRX) represents approximately 0.00% of Steven Cohen's publicly disclosed stock portfolio, making it one of their key holdings.
Steven Cohen's peak holding in Recursion Pharmaceuticals, Inc. (RXRX) was 1,470,200 shares, as reported at the end of Q4 2023.